Dissecting the Decision: Investigators Discuss Emerging Treatment Strategies and Novel Approaches in Gynecologic Cancers


Clinical Investigators Provide Their Perspectives on Gynecologic Cancer: Video Proceedings from 3 Live Events at the Society of Gynecologic Oncology’s 2017 Annual Meeting on Women’s Cancer

This spring our education group hosted 3 unique events at the Society of Gynecologic Oncology’s Annual Meeting on Women’s Cancer. We started off by exploring novel agents and treatment approaches across ovarian, cervical and endometrial cancers. We then shifted our focus to a case-based event on the management of uterine sarcomas, a rare group of diseases that has nonetheless seen a number of recent advances. Finally, we wrapped things up with a session dedicated to the rapidly evolving role of PARP inhibition in the treatment of ovarian cancer.

Michael Birrer, MD, PhD
Director, UAB Comprehensive Cancer Center
University of Alabama at Birmingham
Birmingham, Alabama

Bradley J Monk, MD
Professor and Director
Division of Gynecologic Oncology
Vice Chair, Department of Obstetrics and Gynecology
University of Arizona Cancer Center — Phoenix
Creighton University School of Medicine at Dignity Health
St Joseph’s Hospital and Medical Center
Phoenix, Arizona

Angeles Alvarez Secord, MD, MHSc
Professor
Department of Obstetrics and Gynecology
Division of Gynecologic Oncology
Duke Cancer Institute
Durham, North Carolina
 
Robert L Coleman, MD
Professor and Deputy Chairman
Vice Chair, Clinical Research
Ann Rife Cox Chair in Gynecology
Department of Gynecologic Oncology and Reproductive Medicine
The University of Texas
MD Anderson Cancer Center
Houston, Texas

Jonathan A Ledermann, MD
Professor of Medical Oncology
Clinical Director
University College London (UCL)
Cancer Institute
Clinical Director, UCL Cancer Institute
Director, The Cancer Research UK
and UCL Cancer Trials Centre
London, United Kingdom

Ursula A Matulonis, MD
Medical Director and Program Leader
Gynecologic Oncology Program
Associate Professor of Medicine
Harvard Medical School
Dana-Farber Cancer Institute
Boston, Massachusetts

Richard T Penson, MD, MRCP
Associate Professor of Medicine
Harvard Medical School
Clinical Director, Medical Oncology
Massachusetts General Hospital
Boston, Massachusetts

 
Suzanne George, MD
Clinical Director
Center for Sarcoma and Bone Oncology
Senior Physician
Associate Professor of Medicine
Harvard Medical School
Dana-Farber Cancer Institute
Boston, Massachusetts

David Scott Miller, MD
Amy and Vernon E Faulconer Distinguished Chair in Medical Science
Dallas Foundation Chair in Gynecologic Oncology
Professor and Chief
Division of Gynecologic Oncology
Department of Obstetrics and Gynecology
Harold C Simmons Comprehensive Cancer Center
UT Southwestern Medical Center
Dallas, Texas

Bradley J Monk, MD
Professor and Director
Division of Gynecologic Oncology
Vice Chair, Department of Obstetrics and Gynecology
University of Arizona Cancer Center — Phoenix
Creighton University School of Medicine at Dignity Health
St Joseph’s Hospital and Medical Center
Phoenix, Arizona

Brian A Van Tine, MD, PhD
Assistant Professor of Medicine
Department of Medicine at Washington University
St Louis, Missouri